Question 1

What is MGX's last price and market cap on Chartloom?

Accepted Answer

The overview shows a last price near n/a and market cap near 0.04B (subject to data latency), alongside the price snapshot and profile on this page.

Question 2

What P/E and 52-week range are shown for MGX?

Accepted Answer

P/E (TTM) is n/a and 52-week range is $0.96 to $3.95 when available from the data feed; see the metrics and chart on this page.

Question 3

Where do Chartloom’s MGX figures come from?

Accepted Answer

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

Question 4

What trailing-twelve-month financials does Chartloom show for MGX?

Accepted Answer

The company profile lists revenue (TTM) near $22M, net income (TTM) near $-8.60B, EPS (TTM) near $-2.30 when available from the market-data feed. Figures are informational and may lag live markets.

Question 5

Where is Metagenomi Therapeutics Inc based, and what identifiers does Chartloom list?

Accepted Answer

The company context section lists headquarters in Emeryville, California, US, 37.6M shares outstanding, ISIN US59102M1045 when available from company profile and filing metadata.